New HbA1c Meter Chosen for Study Trial

2200

On November 28, 2000, Bio-Rad Labratories announced that its new instrument for measuring HbA1c levels, called Micromat II, was chosen for use in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. The ACCORD trial is aimed at reducing cardiovascular disease in people with type 2 diabetes. The test will be used to measure the patients HbA1c levels at 60 different test sites throughout the U.S. and Canada.

“We are pleased to be part of the NIH ACCORD study,” said John Hertia, director of Business and Technology Development at Bio-Rad in the press release.

Bio-Rad Laboratories of Hercules, California designed the portable instrument that allows an HbAIc to be measured in five minutes. For more information, call (800) 224-6723 or log onto their Web site at www.bio-rad.com.

Click here to view/write comments
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.